• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.HER2/neu信号通路介导的miR-21上调促进细胞侵袭。
J Biol Chem. 2009 Jul 3;284(27):18515-24. doi: 10.1074/jbc.M109.006676. Epub 2009 May 6.
2
High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.高通量筛选鉴定出对HER2阳性乳腺癌细胞生长至关重要的微小RNA。
Mol Oncol. 2014 Feb;8(1):93-104. doi: 10.1016/j.molonc.2013.10.001. Epub 2013 Oct 11.
3
Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.程序性细胞死亡4(PDCD4)的下调与芳香化酶抑制剂耐药性及雌激素受体阳性乳腺癌的不良预后相关。
Breast Cancer Res Treat. 2015 Jul;152(1):29-39. doi: 10.1007/s10549-015-3446-8. Epub 2015 May 31.
4
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.微小RNA-21将上皮-间质转化与炎症信号联系起来,赋予HER2阳性乳腺癌患者对新辅助曲妥珠单抗和化疗的抗性。
Oncotarget. 2015 Nov 10;6(35):37269-80. doi: 10.18632/oncotarget.5495.
5
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.miRNA 特征可预测乳腺癌中雌激素受体、孕激素受体和 HER2/neu 受体状态。
Breast Cancer Res. 2009;11(3):R27. doi: 10.1186/bcr2257. Epub 2009 May 11.
6
A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.miR-489与HER2-SHP2-MAPK信号轴之间的新型双负反馈环调节乳腺癌细胞增殖和肿瘤生长。
Oncotarget. 2016 Apr 5;7(14):18295-308. doi: 10.18632/oncotarget.7577.
7
ErbB2-intronic microRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling.ErbB2内含子微小RNA-4728:一种新型肿瘤抑制因子及致癌性丝裂原活化蛋白激酶信号通路的拮抗剂
Cell Death Dis. 2015 May 7;6(5):e1742. doi: 10.1038/cddis.2015.116.
8
Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.表达激活型HER2/neu的乳腺癌在体外和体内对吉非替尼敏感,并通过HER2/neu中的一种新的点突变获得耐药性。
Cancer Res. 2007 Jul 15;67(14):6825-43. doi: 10.1158/0008-5472.CAN-07-0765.
9
Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.信号转导与转录激活因子3(Stat3)调节表皮生长因子受体2(ErbB-2)的表达,并利用ErbB-2的核功能来诱导微小RNA-21(miR-21)的表达、程序性细胞死亡蛋白4(PDCD4)的下调以及乳腺癌转移。
Oncogene. 2016 Apr 28;35(17):2208-22. doi: 10.1038/onc.2015.281. Epub 2015 Jul 27.
10
Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.抗肥胖药物奥利司他(赛尼可TM)对乳腺癌细胞的抗肿瘤作用:阻断细胞周期进程、促进凋亡性细胞死亡以及PEA3介导的Her2/neu(erbB-2)癌基因转录抑制。
Ann Oncol. 2005 Aug;16(8):1253-67. doi: 10.1093/annonc/mdi239. Epub 2005 May 3.

引用本文的文献

1
MicroRNAs as promising biomarkers and potential therapeutic agents in breast cancer management: a comprehensive review.微小RNA作为乳腺癌管理中有前景的生物标志物和潜在治疗剂:一项综合综述。
Ann Med Surg (Lond). 2024 Apr 22;86(6):3543-3550. doi: 10.1097/MS9.0000000000002075. eCollection 2024 Jun.
2
A novel method to identify and characterize personalized functional driver lncRNAs in cancer samples.一种在癌症样本中鉴定和表征个性化功能性驱动长链非编码RNA的新方法。
Comput Struct Biotechnol J. 2023 Mar 24;21:2471-2482. doi: 10.1016/j.csbj.2023.03.041. eCollection 2023.
3
The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.程序性细胞死亡4在胃肠道转化细胞中的作用、相互作用及其受微小RNA的调控
Front Oncol. 2022 Jun 29;12:903374. doi: 10.3389/fonc.2022.903374. eCollection 2022.
4
Dissecting the Roles of PDCD4 in Breast Cancer.剖析PDCD4在乳腺癌中的作用
Front Oncol. 2022 Jun 20;12:855807. doi: 10.3389/fonc.2022.855807. eCollection 2022.
5
Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease.重新审视 miR-200 家族:五兄妹在发育和疾病中的关键作用。
Biomolecules. 2022 Jun 3;12(6):781. doi: 10.3390/biom12060781.
6
MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer.微小RNA表达谱预测接受根治性治疗的结直肠癌患者的淋巴结状态和疾病复发情况。
Cancers (Basel). 2022 Apr 23;14(9):2109. doi: 10.3390/cancers14092109.
7
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.循环和细胞内微小RNA作为新辅助化疗治疗HER2阳性早期乳腺癌的预后和预测因素:文献综述
Cancers (Basel). 2021 Sep 29;13(19):4894. doi: 10.3390/cancers13194894.
8
MiR-21 Is Required for the Epithelial-Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells.miR-21 在 MDA-MB-231 乳腺癌细胞上皮间质转化中起关键作用。
Int J Mol Sci. 2021 Feb 4;22(4):1557. doi: 10.3390/ijms22041557.
9
Breast Cancer Response to Therapy: Can microRNAs Lead the Way?乳腺癌治疗反应:微小 RNA 能否引领前路?
J Mammary Gland Biol Neoplasia. 2021 Jun;26(2):157-178. doi: 10.1007/s10911-021-09478-3. Epub 2021 Jan 21.
10
Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.槐定碱(MASL)对口腔鳞状细胞癌(OSCC)基因表达和转录信号通路的影响。
J Cancer Res Clin Oncol. 2021 Feb;147(2):445-457. doi: 10.1007/s00432-020-03456-8. Epub 2020 Nov 17.

本文引用的文献

1
Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.程序性细胞死亡4通过增加金属蛋白酶组织抑制剂-2的表达来抑制乳腺癌细胞的侵袭。
Breast Cancer Res Treat. 2009 Mar;114(2):203-9. doi: 10.1007/s10549-008-9993-5. Epub 2008 Apr 4.
2
miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism.由AP-1触发的miR-21基因表达通过双负反馈机制得以维持。
J Mol Biol. 2008 May 2;378(3):492-504. doi: 10.1016/j.jmb.2008.03.015. Epub 2008 Mar 15.
3
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.靶向缺失揭示了miR-17至92 miRNA簇家族的重要功能及重叠功能。
Cell. 2008 Mar 7;132(5):875-86. doi: 10.1016/j.cell.2008.02.019.
4
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.淋巴细胞中miR-17-92表达增加的小鼠的淋巴增殖性疾病和自身免疫
Nat Immunol. 2008 Apr;9(4):405-14. doi: 10.1038/ni1575. Epub 2008 Mar 9.
5
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.微小RNA-21在侵袭和转移过程中靶向肿瘤抑制基因。
Cell Res. 2008 Mar;18(3):350-9. doi: 10.1038/cr.2008.24.
6
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.细胞外信号调节激酶(ERK)通过MDM2介导的降解抑制叉头框蛋白O3a(FOXO3a)来促进肿瘤发生。
Nat Cell Biol. 2008 Feb;10(2):138-48. doi: 10.1038/ncb1676. Epub 2008 Jan 20.
7
Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.乳腺癌中特定上皮细胞亚群的微小RNA表达改变。
Cancer Res. 2007 Dec 15;67(24):11612-20. doi: 10.1158/0008-5472.CAN-07-5019.
8
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.程序性细胞死亡4(PDCD4)是乳腺癌细胞中微小RNA miR-21的重要功能靶点。
J Biol Chem. 2008 Jan 11;283(2):1026-33. doi: 10.1074/jbc.M707224200. Epub 2007 Nov 8.
9
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.微小RNA-21(miR-21)在转录后下调肿瘤抑制因子程序性细胞死亡蛋白4(Pdcd4),并促进结直肠癌的侵袭、血管内侵入和转移。
Oncogene. 2008 Apr 3;27(15):2128-36. doi: 10.1038/sj.onc.1210856. Epub 2007 Oct 29.
10
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.人类乳腺癌的MicroRNA表达谱分析确定了肿瘤亚型的新标志物。
Genome Biol. 2007;8(10):R214. doi: 10.1186/gb-2007-8-10-r214.

HER2/neu信号通路介导的miR-21上调促进细胞侵袭。

Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.

作者信息

Huang Tzu-Hsuan, Wu Fangting, Loeb Gabriel B, Hsu Ruby, Heidersbach Amy, Brincat Allison, Horiuchi Dai, Lebbink Robert J, Mo Yin-Yuan, Goga Andrei, McManus Michael T

机构信息

Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA.

出版信息

J Biol Chem. 2009 Jul 3;284(27):18515-24. doi: 10.1074/jbc.M109.006676. Epub 2009 May 6.

DOI:10.1074/jbc.M109.006676
PMID:19419954
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2709372/
Abstract

The cell surface receptor tyrosine kinase HER2/neu enhances tumor metastasis. Recent studies suggest that deregulated microRNA (miRNA) expression promotes invasion and metastasis of cancer cells; we therefore explored the possibility that HER2/neu signaling induces the expression of specific miRNAs involved in this process. We identified a putative oncogenic miRNA, miR-21, whose expression is correlated with HER2/neu up-regulation and is functionally involved in HER2/neu-induced cell invasion. We show that miR-21 is up-regulated via the MAPK (ERK1/2) pathway upon stimulation of HER2/neu signaling in breast cancer cells, and overexpression of other ERK1/2 activators such as RASV12 or ID-1 is sufficient to induce miR-21 up-regulation in HER2/neu-negative breast cancer cells. Furthermore, the metastasis suppressor protein PDCD4 (programmed cell death 4) is down-regulated by miR-21 in breast cancer cells expressing HER2/neu. Our data reveal a mechanism for HER2/neu-induced cancer cell invasion via miRNA deregulation. In addition, our results identify miR-21 as a potential therapeutic target for the prevention of breast cancer invasion and metastasis.

摘要

细胞表面受体酪氨酸激酶HER2/neu可促进肿瘤转移。最近的研究表明,失调的微小RNA(miRNA)表达会促进癌细胞的侵袭和转移;因此,我们探讨了HER2/neu信号传导诱导参与这一过程的特定miRNA表达的可能性。我们鉴定出一种假定的致癌miRNA,即miR-21,其表达与HER2/neu上调相关,并且在功能上参与HER2/neu诱导的细胞侵袭。我们发现,在乳腺癌细胞中刺激HER2/neu信号后,miR-21通过丝裂原活化蛋白激酶(MAPK,细胞外信号调节激酶1/2即ERK1/2)途径上调,并且其他ERK1/2激活剂(如RASV12或ID-1)的过表达足以在HER2/neu阴性乳腺癌细胞中诱导miR-21上调。此外,在表达HER2/neu的乳腺癌细胞中,转移抑制蛋白程序性细胞死亡4(PDCD4)被miR-21下调。我们的数据揭示了一种通过miRNA失调导致HER2/neu诱导癌细胞侵袭的机制。此外,我们的结果确定miR-21是预防乳腺癌侵袭和转移的潜在治疗靶点。